Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Natalee Tanner"'
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 979-984 (2020)
Tumor lysis syndrome (TLS) is an oncological emergency characterized by severe electrolyte disturbance that typically occurs when hematologic cancer patients have been started on systemic chemotherapy. We present an uncommon case of spontaneous TLS (
Externí odkaz:
https://doaj.org/article/d088410ca7c347419270fcc9f51d6f2c
Autor:
John Chang, Boris G. Naraev, Akshjot Puri, Patricia Lucente, Natalee Tanner, Tomislav Dragovich, Janice Desiongco, Madappa N. Kundranda
Publikováno v:
J Gastrointest Oncol
Background Skeletal metastases (SM) in advanced pancreatic ductal adenocarcinoma (PDAC) is an infrequent occurrence that has been previously reported in literature to occur in less than 2.5% of the cases. Complications such as pathological fractures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5095688148d4ad31c71f95ad76fa303b
https://doi.org/10.21037/jgo-20-361
https://doi.org/10.21037/jgo-20-361
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 979-984 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 979-984 (2020)
Tumor lysis syndrome (TLS) is an oncological emergency characterized by severe electrolyte disturbance that typically occurs when hematologic cancer patients have been started on systemic chemotherapy. We present an uncommon case of spontaneous TLS (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d942f801be17208c3d157cd75c00a2b
http://europepmc.org/articles/PMC7506379
http://europepmc.org/articles/PMC7506379
Autor:
Sowbharnika Arivazhagan, M Patrick Stagg, Natalee Tanner, Deepti Kantamani, Madappa N. Kundranda
Publikováno v:
Cureus
We present a case of a 59-year-old male undergoing adjuvant chemotherapy for his pancreatic adenocarcinoma post-surgical resection. He had an acute rise in carbohydrate antigen (CA) 19-9 level, which raised suspicion of metastatic disease. Instead, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20e499b5fc3e4762605a439c1c3c0a49
https://doi.org/10.7759/cureus.17010
https://doi.org/10.7759/cureus.17010
Autor:
Natalee Tanner, Richard Gerkin, Madappa N. Kundranda, Alexandra E Chambers, Tomislav Dragovich, Jacob Frick
Publikováno v:
Journal of Gastrointestinal Oncology. 9:679-686
Background: There are few treatment options in metastatic colorectal cancer (mCRC) after progression on standard chemotherapy. Third and fourth line therapies typically consist of regorafenib or trifluridine-tipiracil, however, clinical benefit of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f2b505d195c71fee34d8556730840f2
https://doi.org/10.21037/jgo.2018.04.08
https://doi.org/10.21037/jgo.2018.04.08
Autor:
Natalee Tanner, George M. Rodgers, David D. Stenehjem, Jeffrey A. Gilreath, Khine Z Win, Nathan Wilson
Publikováno v:
Blood. 126:2319-2319
Introduction Patients with active cancer have a high risk for venous thromboembolism (VTE). The current treatment of choice for cancer-associated thrombosis is low molecular weight heparin (LMWH). Evidence for the efficacy and safety of the target-sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22562c5335a9c5d8fdaafcd8b8365142
https://doi.org/10.1182/blood.v126.23.2319.2319
https://doi.org/10.1182/blood.v126.23.2319.2319